Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies

56Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

Abstract

Aberrant expression and activation of EGF receptor (EGFR) has been implicated in the development and progression of many human cancers. As such, targeted therapeutic inhibition of EGFR, for example by antibodies, is a promising anticancer strategy. The overall efficacy of antibody therapies results from the complex interplay between affinity, valence, tumor penetration and retention, and signaling inhibition. To gain better insight into this relationship, we studied a panel of EGFR single-chain Fv (scFv) antibodies that recognize an identical epitope on EGFR but bind with intrinsic monovalent affinities varying by 280-fold. The scFv were converted to Fab and IgG formats, and investigated for their ability to bind EGFR, compete with EGF binding, and inhibit EGF-mediated downstream signaling and proliferation. We observed that the apparent EGFR-binding affinity for bivalent IgG plateaus at intermediate values of intrinsic affinity of the cognate Fab, leading to a biphasic curve describing the ratio of IgG to Fab affinity. Mathematical modeling of antibody-receptor binding indicated that the biphasic effect results from nonequilibrium assay limitations. This was confirmed by further observation that the potency of EGF competition for antibody binding to EGFR improved with both intrinsic affinity and antibody valence. Similarly, both higher intrinsic affinity and bivalent binding improved the potency of antibodies in blocking cellular signaling and proliferation. Overall, our work indicates that higher intrinsic affinity combined with bivalent binding can achieve avidity that leads to greater in vitro potency of antibodies, which may translate into greater therapeutic efficacy. ©2012 AACR.

References Powered by Scopus

2528Citations
587Readers
Get full text
Get full text

Cited by Powered by Scopus

200Citations
680Readers

Your institution provides access to this article.

Get full text
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhou, Y., Goenaga, A. L., Harms, B. D., Zou, H., Lou, J., Conrad, F., … Marks, J. D. (2012). Impact of intrinsic affinity on functional binding and biological activity of EGFR antibodies. Molecular Cancer Therapeutics, 11(7), 1467–1476. https://doi.org/10.1158/1535-7163.MCT-11-1038

Readers over time

‘12‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘24‘2505101520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 41

55%

Researcher 31

42%

Professor / Associate Prof. 2

3%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 35

47%

Biochemistry, Genetics and Molecular Bi... 22

30%

Pharmacology, Toxicology and Pharmaceut... 11

15%

Engineering 6

8%

Save time finding and organizing research with Mendeley

Sign up for free
0